JLB & Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-17,392
Closed -$1.54M 72
2017
Q2
$1.54M Buy
+17,392
New +$1.47M 0.39% 54
2016
Q4
$1.61M Buy
22,555
+123
+0.5% +$9.66K 0.43% 54
2016
Q3
$1.94M Sell
22,432
-1,342
-6% -$117K 0.53% 50
2016
Q2
$2.06M Buy
23,774
+2,246
+10% +$182K 0.58% 51
2016
Q1
$1.73M Sell
21,528
-2,349
-10% -$177K 0.44% 52
2015
Q4
$1.84M Sell
23,877
-770
-3% -$58K 0.57% 49
2015
Q3
$1.65M Sell
24,647
-650
-3% -$47.9K 0.53% 52
2015
Q2
$1.87M Sell
25,297
-20
-0.1% -$1.53K 0.58% 51
2015
Q1
$1.97M Sell
25,317
-173
-0.7% -$13.1K 0.62% 50
2014
Q4
$1.84M Buy
25,490
+225
+0.9% +$15.6K 0.61% 49
2014
Q3
$1.56M Sell
25,265
-595
-2% -$37.8K 0.56% 51
2014
Q2
$1.65M Sell
25,860
-360
-1% -$21.9K 0.6% 51
2014
Q1
$1.61M Buy
26,220
+463
+2% +$27K 0.6% 52
2013
Q4
$1.48M Buy
25,757
+1,735
+7% +$98.4K 0.56% 51
2013
Q3
$1.28M Buy
24,022
+1,112
+5% +$59.8K 0.54% 51
2013
Q2
$1.18M Buy
+22,910
New +$1.13M 0.54% 51

Other funds holding MDT

JLB & Associates's MDT Position: Q3 2017 in Review

JLB & Associates sold out of Medtronic (MDT) in Q3 2017, closing a stake of 17,392 shares — an estimated $1.54M sold.

JLB & Associates first reported a position in MDT in Q2 2013 and held it in 16 quarters. The position peaked at $2.06M in Q2 2016. 1,291 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

  • JLB & Associates reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
  • JLB & Associates sold 17,392 Medtronic shares in Q3 2017, an estimated $1.54M.
  • JLB & Associates first reported a position in Medtronic in Q2 2013 and held it in 16 quarters.
  • JLB & Associates's Medtronic position peaked at $2.06M in Q2 2016.
  • 1,291 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on JLB & Associates's 13F filing for Q3 2017, filed 12 Oct 2017.